Molecular biomarkers for vascular cognitive impairment and dementia: the current status and directions for the future.
作者信息
Hosoki Satoshi, Sachdev Perminder S
机构信息
Centre for Healthy Brain Ageing, Discipline of Psychiatry and Mental Health, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia (Hosoki S, Sachdev PS).
Department of Neurology, National Cerebral and Cardiovascular Center, Osaka, Japan (Hosoki S).
出版信息
Neural Regen Res. 2024 Dec 1;19(12):2579-2580. doi: 10.4103/NRR.NRR-D-23-01938. Epub 2024 Mar 1.
Abstract
摘要
相似文献
1
Molecular biomarkers for vascular cognitive impairment and dementia: the current status and directions for the future.
Neural Regen Res. 2024 Dec 1;19(12):2579-2580. doi: 10.4103/NRR.NRR-D-23-01938. Epub 2024 Mar 1.
2
Vascular cognitive impairment and dementia: Mechanisms, treatment, and future directions.
Int J Stroke. 2024 Oct;19(8):838-856. doi: 10.1177/17474930241279888.
3
Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
Ann Pharmacother. 2009 Jul;43(7):1310-23. doi: 10.1345/aph.1L703. Epub 2009 Jul 7.
4
Post-Stroke Cognitive Impairment and Dementia.
Circ Res. 2022 Apr 15;130(8):1252-1271. doi: 10.1161/CIRCRESAHA.122.319951. Epub 2022 Apr 14.
5
Blood Pressure and Vascular Cognitive Impairment.
Stroke. 2022 Apr;53(4):1104-1113. doi: 10.1161/STROKEAHA.121.036140. Epub 2022 Mar 10.
6
Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia.
Biol Sex Differ. 2023 May 23;14(1):34. doi: 10.1186/s13293-023-00518-7.
7
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
8
Emerging Biomarkers in Vascular Cognitive Impairment and Dementia: From Pathophysiological Pathways to Clinical Application.
Int J Mol Sci. 2019 Jun 8;20(11):2812. doi: 10.3390/ijms20112812.
9
The ROSAS Cohort: A Prospective, Longitudinal Study of Biomarkers for Alzheimer's Disease. Strategy, Methods and Initial Results.
J Prev Alzheimers Dis. 2017;4(3):183-193. doi: 10.14283/jpad.2017.8.
10
Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis.
Geroscience. 2020 Dec;42(6):1499-1525. doi: 10.1007/s11357-020-00252-7. Epub 2020 Oct 4.
引用本文的文献
1
Correlation between carotid artery ultrasound parameters and lacunar infarction.
BMC Med Imaging. 2025 Aug 12;25(1):325. doi: 10.1186/s12880-025-01859-y.
2
Functional Near-Infrared Spectroscopy Signal as a Potential Biomarker for White Matter Hyperintensity Progression in Patients With Subcortical Vascular Cognitive Impairment: A Pilot Study.
Brain Behav. 2025 Jun;15(6):e70598. doi: 10.1002/brb3.70598.
3
Imaging-validated correlates and implications of the pathophysiologic mechanisms of ageing-related cerebral large artery and small vessel diseases: a systematic review and meta-analysis.
Behav Brain Funct. 2025 Apr 22;21(1):12. doi: 10.1186/s12993-025-00274-1.
本文引用的文献
1
Analysis of biomarkers in speculative CNS-enriched extracellular vesicles for parkinsonian disorders: a comprehensive systematic review and diagnostic meta-analysis.
J Neurol. 2024 Apr;271(4):1680-1706. doi: 10.1007/s00415-023-12093-3. Epub 2023 Dec 16.
2
Molecular biomarkers for vascular cognitive impairment and dementia.
Nat Rev Neurol. 2023 Dec;19(12):737-753. doi: 10.1038/s41582-023-00884-1. Epub 2023 Nov 13.
3
Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid.
Nat Protoc. 2023 Apr;18(4):1179-1196. doi: 10.1038/s41596-022-00787-3. Epub 2023 Jan 18.
4
Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-β in patients with subcortical small-vessel disease.
Alzheimers Dement (Amst). 2022 Mar 25;14(1):e12296. doi: 10.1002/dad2.12296. eCollection 2022.
5
Transcriptomic mapping of the human cerebrovasculature.
Nat Rev Neurol. 2022 Jun;18(6):319-320. doi: 10.1038/s41582-022-00650-9.
6
Revisiting the neurovascular unit.
Nat Neurosci. 2021 Sep;24(9):1198-1209. doi: 10.1038/s41593-021-00904-7. Epub 2021 Aug 5.
7
Oral Carriage of Harboring the Gene Relates to an Increased Incidence of Cerebral Microbleeds.
Stroke. 2020 Dec;51(12):3632-3639. doi: 10.1161/STROKEAHA.120.029607. Epub 2020 Nov 5.
8
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
JAMA. 2020 Aug 25;324(8):772-781. doi: 10.1001/jama.2020.12134.
9
Shared proteomic effects of cerebral atherosclerosis and Alzheimer's disease on the human brain.
Nat Neurosci. 2020 Jun;23(6):696-700. doi: 10.1038/s41593-020-0635-5. Epub 2020 May 18.
10
Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia.
Front Aging Neurosci. 2020 Apr 14;12:80. doi: 10.3389/fnagi.2020.00080. eCollection 2020.
Zotero 插件